Centessa Pharmaceuticals (CNTA) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to -$246.2 million.
- Centessa Pharmaceuticals' Enterprise Value rose 5250.95% to -$246.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$246.2 million, marking a year-over-year increase of 5250.95%. This contributed to the annual value of -$482.2 million for FY2024, which is 8794.73% down from last year.
- Centessa Pharmaceuticals' Enterprise Value amounted to -$246.2 million in Q3 2025, which was up 5250.95% from -$250.7 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Enterprise Value ranged from a high of -$230.2 million in Q1 2024 and a low of -$544.5 million during Q1 2022
- For the 4-year period, Centessa Pharmaceuticals' Enterprise Value averaged around -$357.5 million, with its median value being -$303.6 million (2023).
- In the last 5 years, Centessa Pharmaceuticals' Enterprise Value tumbled by 8794.73% in 2024 and then soared by 5250.95% in 2025.
- Quarter analysis of 4 years shows Centessa Pharmaceuticals' Enterprise Value stood at -$393.6 million in 2022, then soared by 34.83% to -$256.5 million in 2023, then tumbled by 87.95% to -$482.2 million in 2024, then skyrocketed by 48.94% to -$246.2 million in 2025.
- Its last three reported values are -$246.2 million in Q3 2025, -$250.7 million for Q2 2025, and -$284.5 million during Q1 2025.